Institute for Clinical and Economic Review releases draft evidence report on treatments for tardive dyskinesia

ICER

2 October 2017 - Public comment period now open until 30 October; requests to make oral comment during public meeting also being accepted.

The Institute for Clinical and Economic Review has released a draft evidence report assessing the comparative clinical effectiveness and value of therapies to treat tardive dyskinesia, a movement disorder often associated with long-term use of antipsychotic medications. 

The report, along with draft voting questions, will be open to public comment for four weeks.

Read ICER announcement


Michael Wonder

Posted by:

Michael Wonder